These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8500232)

  • 21. Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate.
    Cohn JN; Archibald DG; Francis GS; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Flohr KH
    Circulation; 1987 May; 75(5 Pt 2):IV49-54. PubMed ID: 3552302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of vasodilator drugs in congestive heart failure.
    Med Lett Drugs Ther; 1978 Oct; 20(20):89-91. PubMed ID: 703684
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of cardiac failure with vasodilators (author's transl)].
    Imhof P
    Schweiz Rundsch Med Prax; 1978 May; 67(22):219-29. PubMed ID: 418395
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of vasodilator therapy on mortality in chronic congestive heart failure.
    Cohn JN
    Eur Heart J; 1988 Jan; 9 Suppl A():171-3. PubMed ID: 3044793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group.
    Carson P; Ziesche S; Johnson G; Cohn JN
    J Card Fail; 1999 Sep; 5(3):178-87. PubMed ID: 10496190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Modern vasodilator medication in refractory cardiac insufficiency].
    Stanciu L; Branea I; Riviş I; Radivoievici A; Mancaş S; Păunescu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(2):129-34. PubMed ID: 6139858
    [No Abstract]   [Full Text] [Related]  

  • 27. [Vasodilator agents in the treatment of heart failure].
    Prati PL; Manfrin M
    G Ital Cardiol; 1978; 8(1):1-11. PubMed ID: 415927
    [No Abstract]   [Full Text] [Related]  

  • 28. Vasodilators in the treatment of congestive heart failure.
    Ciafone RA
    Conn Med; 1983 Oct; 47(10):614-8. PubMed ID: 6414758
    [No Abstract]   [Full Text] [Related]  

  • 29. [Vasodilator therapy in cardiac failure].
    Akatsuka N
    Nihon Rinsho; 1993 May; 51(5):1276-80. PubMed ID: 8101237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasodilator therapy of congestive heart failure.
    Cohn JN
    Adv Intern Med; 1980; 26():293-315. PubMed ID: 6784453
    [No Abstract]   [Full Text] [Related]  

  • 31. Isosorbide dinitrate/hydralazine: its role in the treatment of heart failure.
    Thadani U; Jacob RG
    Drugs Today (Barc); 2008 Dec; 44(12):925-37. PubMed ID: 19198701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. V-HeFT positive for enalapril.
    Br J Hosp Med; 1991 Apr; 45(4):233. PubMed ID: 1676327
    [No Abstract]   [Full Text] [Related]  

  • 33. Is there a drug of choice for vasodilator therapy in patients with refractory heart failure?
    Packer M
    Chest; 1980 Jan; 77(1):7-9. PubMed ID: 7351152
    [No Abstract]   [Full Text] [Related]  

  • 34. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.
    Cohn JN; Johnson G; Ziesche S; Cobb F; Francis G; Tristani F; Smith R; Dunkman WB; Loeb H; Wong M
    N Engl J Med; 1991 Aug; 325(5):303-10. PubMed ID: 2057035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
    Boden WE; Ziesche S; Carson PE; Conrad CH; Syat D; Cohn JN
    Am J Cardiol; 1996 May; 77(12):1078-82. PubMed ID: 8644661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of vasodilator therapy in congestive heart failure. Effects on mortality.
    Greenberg B
    Cardiol Clin; 1994 Feb; 12(1):87-99. PubMed ID: 8181028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies of Left Ventricular Dysfunction (SOLVD)--new hope for heart failure.
    S Afr Med J; 1991 Nov; Suppl():1-8. PubMed ID: 1957226
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of vasodilator agents in chronic heart failure].
    Bussmann WD
    Med Klin; 1981 Apr; 76(9):249-53. PubMed ID: 6456408
    [No Abstract]   [Full Text] [Related]  

  • 39. Vasodilator therapy of hypertensive acute left ventricular failure: comparison of captopril-prazosin with hydralazine-isosorbide dinitrate.
    Adigun AQ; Ajayi OE; Sofowora GG; Ajayi AA
    Int J Cardiol; 1998 Nov; 67(1):81-6. PubMed ID: 9880204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of isosorbide dinitrate and hydralazine in the management of heart failure in black patients, with a focus on a new fixed-dose combination.
    Cheng JW
    Clin Ther; 2006 May; 28(5):666-78. PubMed ID: 16861089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.